Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 1294 entries
View as:

Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01821846 Org: User:
Start: 11/20/13 End: 03/08/17 Due: 03/08/18

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04862923 Org: User:
Start: 05/12/21 End: 08/31/23 Due: 08/31/24

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)

Phase: N/A Priority: Normal
NCT ID: NCT03929679 Org: User:
Start: 05/28/19 End: 11/24/20 Due: 11/24/21

Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00943501 Org: User:
Start: 11/30/09 End: 09/30/11 Due: 09/30/12

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03811561 Org: User:
Start: 05/08/19 End: 11/07/27 Due: 11/07/28

A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT06260709 Org: User:
Start: 02/20/24 End: 08/15/28 Due: 08/15/29

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT06200207 Org: User:
Start: 04/01/24 End: 01/12/27 Due: 01/12/28

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

Phase: N/A Priority: Normal
NCT ID: NCT05514535 Org: User:
Start: 08/29/22 End: 04/09/25 Due: 04/09/26

Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT01561352 Org: User:
Start: 09/30/01 End: 11/30/03 Due: 11/30/04

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka

Phase: N/A Priority: Normal
NCT ID: NCT01957592 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT05094934 Org: User:
Start: 11/09/21 End: 08/24/22 Due: 08/24/23

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

Phase: N/A Priority: Normal
NCT ID: NCT05352815 Org: User:
Start: 06/01/22 End: 04/23/24 Due: 04/23/25

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec

Phase: N/A Priority: Normal
NCT ID: NCT01865279 Org: User:
Start: 12/31/05 End: 04/30/06 Due: 04/30/07

First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

Phase: N/A Priority: Normal
NCT ID: NCT03617081 Org: User:
Start: 08/09/18 End: 12/13/18 Due: 12/13/19

Dose Response to Recombinant Factor VIIa When Administered for Bleed

Phase: N/A Priority: Normal
NCT ID: NCT00104455 Org: User:
Start: 06/30/04 End: 11/30/04 Due: 11/30/05

A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06780449 Org: User:
Start: 02/10/25 End: 11/17/28 Due: 11/17/29

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001

Phase: N/A Priority: Normal
NCT ID: NCT02868229 Org: User:
Start: 09/12/16 End: 12/11/18 Due: 12/11/19

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Phase: N/A Priority: Normal
NCT ID: NCT00184743 Org: User:
Start: 12/06/03 End: 12/28/05 Due: 12/28/06

Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)

Phase: N/A Priority: Normal
NCT ID: NCT02321878 Org: User:
Start: 12/15/14 End: 06/16/17 Due: 06/16/18

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02920385 Org: User:
Start: 10/10/16 End: 06/16/17 Due: 06/16/18

Novofine Autocover Safety Needle Versus BD Safety Glide

Phase: N/A Priority: Normal
NCT ID: NCT00121355 Org: User:
Start: 07/31/05 End: 06/30/06 Due: 06/30/07

The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction

Phase: N/A Priority: Normal
NCT ID: NCT01542476 Org: User:
Start: 08/31/06 End: 10/31/07 Due: 10/31/08

PROPACT: Retrospective Prophylaxis Patient Case Collection

Phase: N/A Priority: Normal
NCT ID: NCT00882778 Org: User:
Start: 04/30/09 End: 05/31/10 Due: 05/31/11

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT02870231 Org: User:
Start: 08/18/16 End: 09/03/17 Due: 09/03/18

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations

Phase: N/A Priority: Normal
NCT ID: NCT01680328 Org: User:
Start: 08/31/12 End: 10/31/12 Due: 10/31/13